[PDF][PDF] Transcriptomics identify CD9 as a marker of murine IL-10-competent regulatory B cells

J Sun, J Wang, E Pefanis, J Chao, G Rothschild… - Cell reports, 2015 - cell.com
J Sun, J Wang, E Pefanis, J Chao, G Rothschild, I Tachibana, JK Chen, II Ivanov, R Rabadan
Cell reports, 2015cell.com
Regulatory B cells (Breg) have immune suppressive functions in various autoimmune/
inflammation models and diseases and are found to be enriched in diverse B cell subsets.
The lack of a unique marker or set of markers efficiently identifying Breg cells impedes
detailed investigation into their origin, development, and immunological roles. Here, we
perform transcriptome analysis of IL-10-expressing B cells to identify key regulators for Breg
biogenesis and function and identify CD9, a tetraspanin-family transmembrane protein, as a …
Summary
Regulatory B cells (Breg) have immune suppressive functions in various autoimmune/inflammation models and diseases and are found to be enriched in diverse B cell subsets. The lack of a unique marker or set of markers efficiently identifying Breg cells impedes detailed investigation into their origin, development, and immunological roles. Here, we perform transcriptome analysis of IL-10-expressing B cells to identify key regulators for Breg biogenesis and function and identify CD9, a tetraspanin-family transmembrane protein, as a key surface marker for most mouse IL-10+ B cells and their progenitors. CD9 plays a role in the suppressive function of IL-10+ B cells in ex vivo T cell proliferation assays through a mechanism that is dependent upon B/T cell interactions. CD9+ B cells also demonstrate inhibition of Th1-mediated contact hypersensitivity in an in vivo model system. Taken together, our findings implicate CD9 in the immunosuppressive activity of regulatory B cells.
cell.com